ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.51
-0.35%
US Tech 100
20,562.00
0.10%
S&P 500
5,995.54
0.38%
US Dollar vs CAD
1.39318
0.00%
Bitcoin
80,901.91
5.37%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Goldfield Corp (GV)

  7. Goldfield Corp (GV) News

GV

Goldfield (GV)

Goldfield Corp
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:GV
DateTimeSourceHeadlineSymbolCompany
01/24/20231:00AMBusiness WireGenomic Vision renforce sa direction en accueillant Frédéric Hammel au poste de Directeur des OpérationsAMEX:GVGoldfield Corp
01/24/20231:00AMBusiness WireGenomic Vision Strengthens Leadership Team With the Appointment of Frederic Hammel as Chief Operating OfficerAMEX:GVGoldfield Corp
01/13/202310:45AMBusiness WireGenomic Vision : Bilan semestriel du Contrat de Liquidité contracté avec CM-CIC SecuritiesAMEX:GVGoldfield Corp
01/05/202312:00AMBusiness WireGenomic Vision Announces Successful Beta Testing of FiberSmart®AMEX:GVGoldfield Corp
01/05/202312:00AMBusiness WireGenomic Vision annonce la réussite du bêta test de FiberSmart®AMEX:GVGoldfield Corp
11/29/20221:00AMBusiness WireGenomic Vision’s Cutting-Edge TeloSizer® Application to be Used in Cancer ResearchAMEX:GVGoldfield Corp
11/29/20221:00AMBusiness WireTeloSizer®, application de pointe développée par Genomic Vision, mise au service de la recherche sur le cancerAMEX:GVGoldfield Corp
11/10/202210:45AMBusiness WireGenomic Vision : Nombre total d’actions et de droits de voteAMEX:GVGoldfield Corp
11/07/202212:00AMBusiness WireGenomic Vision and Cambridge Consultants, Part of Capgemini, Announce the Development of an Innovative Technology Platform for In-depth Genomic AnalysisAMEX:GVGoldfield Corp
11/07/202212:00AMBusiness WireGenomic Vision et Cambridge Consultants, filiale de Capgemini, annoncent le développement d'une plateforme technologique innovante dédiée à l'analyse génomiqueAMEX:GVGoldfield Corp
10/27/202211:00AMBusiness WireGenomic Vision : Information financière du 3ème trimestre 2022AMEX:GVGoldfield Corp
10/27/202211:00AMBusiness WireGenomic Vision: Financial Information for the Third Quarter of 2022AMEX:GVGoldfield Corp
10/24/202212:30AMBusiness WireGenomic Vision : communiqué relatif aux changements au sein de la gouvernanceAMEX:GVGoldfield Corp
10/24/202212:30AMBusiness WireGenomic Vision: Press Release Regarding Changes in the Company’s GovernanceAMEX:GVGoldfield Corp
09/29/202211:00AMBusiness WireGENOMIC VISION : RÉSULTATS SEMESTRIELS 2022AMEX:GVGoldfield Corp
09/29/202211:00AMBusiness WireGenomic Vision: First-half 2022 ResultsAMEX:GVGoldfield Corp
09/06/202211:00AMBusiness WireGenomic Vision Announces the Issuance of the 1st Tranche of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €30 MillionAMEX:GVGoldfield Corp
09/06/202211:00AMBusiness WireGenomic Vision annonce le tirage de la 1ère tranche de 2 M€ dans le cadre du programme de financement conclu avec Winance pour un montant maximum de 30 M€AMEX:GVGoldfield Corp
07/22/202211:29AMBusiness WireGenomic Vision: Financial Information for the First Half of 2022AMEX:GVGoldfield Corp
07/22/202211:29AMBusiness WireGenomic Vision : Information financière du 1er semestre 2022AMEX:GVGoldfield Corp
07/18/202212:00AMBusiness WireGENOMIC VISION : Apport complémentaire au contrat de liquidité conclu avec CM-CIC SecuritiesAMEX:GVGoldfield Corp
07/18/202212:00AMBusiness WireGenomic Vision: Additional Contribution to the Liquidity Contract Concluded with CM-CIC SecuritiesAMEX:GVGoldfield Corp
07/13/202211:00AMBusiness WireGenomic Vision: Changes in the Company’s GovernanceAMEX:GVGoldfield Corp
07/13/202211:00AMBusiness WireGenomic Vision : changements au sein de la gouvernanceAMEX:GVGoldfield Corp
07/07/202210:45AMBusiness WireGenomic Vision : Bilan semestriel du Contrat de Liquidité contracté avec CM-CIC SecuritiesAMEX:GVGoldfield Corp
06/27/202211:00AMBusiness WireGenomic Vision: Report de l’assemblée générale ordinaire des actionnaires du 28 juin 2022AMEX:GVGoldfield Corp
06/23/202211:00AMBusiness WireGenomic Vision Obtains the Renewal of the ISO 13485 : 2016 CertificationAMEX:GVGoldfield Corp
06/23/202211:00AMBusiness WireGenomic Vision obtient le renouvellement de sa certification ISO 13485 : 2016AMEX:GVGoldfield Corp
06/16/202212:30PMBusiness WireGenomic Vision obtient un nouveau brevet pour sa technique de « Caractérisation Physique des télomères » basée sur le peignage moléculaireAMEX:GVGoldfield Corp
06/16/202212:30PMBusiness WireGenomic Vision granted a new patent for its “Physical Characterization of Telomeres” technique based on molecular combingAMEX:GVGoldfield Corp
 Showing the most relevant articles for your search:AMEX:GV

Your Recent History

LSE
IY25
Citi Fun 24
KOSPI
009240
Hanssem
NASDAQ
AAZTNXX
Barclays Bank Plc Issuer...
ASX
DLM
Dominion Minerals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved